Cover Image
市場調查報告書

POC (照護現場) 分析設備的全球市場:醫療設備的開發平台評估

Point-of-Care (POC) Analyzers - Medical Devices Pipeline Assessment, 2016

出版商 GlobalData 商品編碼 363398
出版日期 內容資訊 英文 64 Pages
訂單完成後即時交付
價格
Back to Top
POC (照護現場) 分析設備的全球市場:醫療設備的開發平台評估 Point-of-Care (POC) Analyzers - Medical Devices Pipeline Assessment, 2016
出版日期: 2016年07月04日 內容資訊: 英文 64 Pages
簡介

面向 本報告提供全球POC (Point of Care:臨床現場) 分析設備的市場上的主要開發中產品與臨床實驗的進展調查,產品的功能、特性比較分析 (臨床實驗的各進展階段) ,再加上主要企業簡介及代表性產品,近來的市場動靜 (業績報告、資本交易趨勢等) 的資訊彙整,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • POC分析設備概要

第3章 臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:各估計認證時期

第4章 臨床實驗中的開發中產品:各企業

  • POC分析設備的企業:各臨床實驗階段的開發中產品
  • POC分析設備:各臨床實驗階段的開發中產品

第5章 POC分析設備市場:企業、產品概要

  • Akers Biosciences, Inc.
    • 開發中產品及進行中的臨床實驗概要
  • Akonni Biosystems, Inc.
  • ApoCell, Inc.
  • Attophotonics Biosciences GmbH
  • Bio-Alternative Medical Devices Ltd
  • BioDirection, Inc.
  • BioMedomics, Inc
  • bioMerieux S.A.
  • Biopico Systems Inc.
  • Boston University
  • Cepheid
  • Co-Diagnostics HBDC, Inc.
  • Indian Institute of Technology, Madras
  • John Hopkins University
  • Magna Diagnostics GmbH
  • McKesson Corporation
  • Nanomix, Inc.
  • OncoGenesis
  • Phoenix Biosystems Inc
  • PositiveID Corporation
  • Quanterix Corporation
  • Radisens Diagnostics Limited
  • Rapid Biosensor Systems
  • SenGenix, Inc.
  • Thermal Gradient, Inc.
  • University of Alberta
  • University of California, Berkeley
  • University of California, Davis
  • Wellstat Diagnostics, LLC
  • Xen Biofluidx Inc

第6章 POC分析設備市場:目前的趨勢 (共3件)

第7章 附錄

圖表一覽

目錄
Product Code: GDME0212EPD

GlobalData's Medical Devices sector report, "Point-of-Care (POC) Analyzers - Medical Devices Pipeline Assessment, 2016" provides an overview of Point-of-Care (POC) Analyzers currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Point-of-Care (POC) Analyzers pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Point-of-Care (POC) Analyzers under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Point-of-Care (POC) Analyzers and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Point-of-Care (POC) Analyzers under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Point-of-Care (POC) Analyzers Overview

3. Products under Development

  • 3.1. Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development
  • 3.2. Point-of-Care (POC) Analyzers - Pipeline Products by Territory
  • 3.3. Point-of-Care (POC) Analyzers - Pipeline Products by Regulatory Path
  • 3.4. Point-of-Care (POC) Analyzers - Pipeline Products by Estimated Approval Date

4. Point-of-Care (POC) Analyzers - Pipeline Products under Development by Companies

  • 4.1. Point-of-Care (POC) Analyzers Companies - Pipeline Products by Stage of Development
  • 4.2. Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development

5. Point-of-Care (POC) Analyzers Companies and Product Overview

  • 5.1. Akers Biosciences, Inc. Company Overview
    • 5.1.1. Akers Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Akonni Biosystems, Inc. Company Overview
    • 5.2.1. Akonni Biosystems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. ApoCell, Inc. Company Overview
    • 5.3.1. ApoCell, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Attophotonics Biosciences GmbH Company Overview
    • 5.4.1. Attophotonics Biosciences GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Bio-Alternative Medical Devices Ltd Company Overview
    • 5.5.1. Bio-Alternative Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. BioDirection, Inc. Company Overview
    • 5.6.1. BioDirection, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. BioMedomics, Inc Company Overview
    • 5.7.1. BioMedomics, Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. bioMerieux S.A. Company Overview
    • 5.8.1. bioMerieux S.A. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. Biopico Systems Inc. Company Overview
    • 5.9.1. Biopico Systems Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. Boston University Company Overview
    • 5.10.1. Boston University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. Cepheid Company Overview
    • 5.11.1. Cepheid Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. Co-Diagnostics HBDC, Inc. Company Overview
    • 5.12.1. Co-Diagnostics HBDC, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. Indian Institute of Technology, Madras Company Overview
    • 5.13.1. Indian Institute of Technology, Madras Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. John Hopkins University Company Overview
    • 5.14.1. John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15. Magna Diagnostics GmbH Company Overview
    • 5.15.1. Magna Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16. McKesson Corporation Company Overview
    • 5.16.1. McKesson Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17. Nanomix, Inc. Company Overview
    • 5.17.1. Nanomix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18. OncoGenesis Company Overview
    • 5.18.1. OncoGenesis Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19. Phoenix Biosystems Inc Company Overview
    • 5.19.1. Phoenix Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20. PositiveID Corporation Company Overview
    • 5.20.1. PositiveID Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21. Quanterix Corporation Company Overview
    • 5.21.1. Quanterix Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22. Radisens Diagnostics Limited Company Overview
    • 5.22.1. Radisens Diagnostics Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23. Rapid Biosensor Systems Company Overview
    • 5.23.1. Rapid Biosensor Systems Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24. SenGenix, Inc. Company Overview
    • 5.24.1. SenGenix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25. Thermal Gradient, Inc. Company Overview
    • 5.25.1. Thermal Gradient, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.26. University of Alberta Company Overview
    • 5.26.1. University of Alberta Pipeline Products & Ongoing Clinical Trials Overview
  • 5.27. University of California, Berkeley Company Overview
    • 5.27.1. University of California, Berkeley Pipeline Products & Ongoing Clinical Trials Overview
  • 5.28. University of California, Davis Company Overview
    • 5.28.1. University of California, Davis Pipeline Products & Ongoing Clinical Trials Overview
  • 5.29. Wellstat Diagnostics, LLC Company Overview
    • 5.29.1. Wellstat Diagnostics, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.30. Xen Biofluidx Inc Company Overview
    • 5.30.1. Xen Biofluidx Inc Pipeline Products & Ongoing Clinical Trials Overview

6. Point-of-Care (POC) Analyzers- Recent Developments

  • 6.1. Jun 29, 2016: McKesson Updates Fiscal 2017KKKKK Guidance
  • 6.2. May 25, 2016: Thermal Gradient Performs 13KKKKK Minute MRSA Test
  • 6.3. Dec 03, 2015: Cepheid Enters into Agreement with Foundation for Innovative New Diagnostics

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development
  • Table 2: Point-of-Care (POC) Analyzers - Pipeline Products by Territory
  • Table 3: Point-of-Care (POC) Analyzers - Pipeline Products by Regulatory Path
  • Table 4: Point-of-Care (POC) Analyzers - Pipeline Products by Estimated Approval Date
  • Table 5: Point-of-Care (POC) Analyzers Companies - Pipeline Products by Stage of Development
  • Table 6: Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development
  • Table 7: Akers Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 8: minDNAnalyzer - Product Status
  • Table 9: minDNAnalyzer - Product Description
  • Table 10: Akonni Biosystems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 11: Point-Of-Care Device - Tuberculosis - Product Status
  • Table 12: Point-Of-Care Device - Tuberculosis - Product Description
  • Table 13: ApoCell, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 14: ApoStream System - Product Status
  • Table 15: ApoStream System - Product Description
  • Table 16: Attophotonics Biosciences GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 17: Nanoparticle Microfluidic Color Device - Product Status
  • Table 18: Nanoparticle Microfluidic Color Device - Product Description
  • Table 19: Bio-Alternative Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 20: Magnetic Immunoassay Detection System - Product Status
  • Table 21: Magnetic Immunoassay Detection System - Product Description
  • Table 22: BioDirection, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 23: Tbit Hand-held System - Product Status
  • Table 24: Tbit Hand-held System - Product Description
  • Table 25: BioMedomics, Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 26: Next Generation Ultra-sensitive Nanotube Platform - Product Status
  • Table 27: Next Generation Ultra-sensitive Nanotube Platform - Product Description
  • Table 28: TR-LFIA Diagnostic Platform - Product Status
  • Table 29: TR-LFIA Diagnostic Platform - Product Description
  • Table 30: bioMerieux S.A. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 31: Magnotech System - Product Status
  • Table 32: Magnotech System - Product Description
  • Table 33: Biopico Systems Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 34: MONITOR System - Product Status
  • Table 35: MONITOR System - Product Description
  • Table 36: Boston University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 37: Molecular Diagnostic Device - Sexually Transmitted Infections - Product Status
  • Table 38: Molecular Diagnostic Device - Sexually Transmitted Infections - Product Description
  • Table 39: Cepheid Pipeline Products & Ongoing Clinical Trials Overview
  • Table 40: GeneXpert Omni - Product Status
  • Table 41: GeneXpert Omni - Product Description
  • Table 42: GeneXpert Omni CLIA-Waived Point-of-Care System - Product Status
  • Table 43: GeneXpert Omni CLIA-Waived Point-of-Care System - Product Description
  • Table 44: Co-Diagnostics HBDC, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 45: LightPCR - Product Status
  • Table 46: LightPCR - Product Description
  • Table 47: Indian Institute of Technology, Madras Pipeline Products & Ongoing Clinical Trials Overview
  • Table 48: Microfluidic Flow Analyzer - Product Status
  • Table 49: Microfluidic Flow Analyzer - Product Description
  • Table 50: John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 51: Point-Of-Care Sensor - Brain Injury - Product Status
  • Table 52: Point-Of-Care Sensor - Brain Injury - Product Description
  • Table 53: Magna Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 54: MAZER System - Product Status
  • Table 55: MAZER System - Product Description
  • Table 56: McKesson Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 57: Proventys PDx System - Product Status
  • Table 58: Proventys PDx System - Product Description
  • Table 59: Nanomix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 60: Nanomix System - Ebola Virus - Product Status
  • Table 61: Nanomix System - Ebola Virus - Product Description
  • Table 62: OncoGenesis Pipeline Products & Ongoing Clinical Trials Overview
  • Table 63: Genesis Point-Of-Care Diagnostic System - Product Status
  • Table 64: Genesis Point-Of-Care Diagnostic System - Product Description
  • Table 65: Phoenix Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 66: Point of Care HIV Combo Device - Product Status
  • Table 67: Point of Care HIV Combo Device - Product Description
  • Table 68: PositiveID Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 69: Firefly Dx System - Zika Virus - Product Status
  • Table 70: Firefly Dx System - Zika Virus - Product Description
  • Table 71: Quanterix Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 72: POC Device - Neurological Injuries - Product Status
  • Table 73: POC Device - Neurological Injuries - Product Description
  • Table 74: Simoa 5.0 - Product Status
  • Table 75: Simoa 5.0 - Product Description
  • Table 76: Radisens Diagnostics Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 77: Radisens Instrument - Product Status
  • Table 78: Radisens Instrument - Product Description
  • Table 79: Rapid Biosensor Systems Pipeline Products & Ongoing Clinical Trials Overview
  • Table 80: Rapid Test Device - Malaria - Product Status
  • Table 81: Rapid Test Device - Malaria - Product Description
  • Table 82: SenGenix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 83: SenGenix Strips And Reader System - Product Status
  • Table 84: SenGenix Strips And Reader System - Product Description
  • Table 85: Thermal Gradient, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 86: FlashDirect-HC - Product Status
  • Table 87: FlashDirect-HC - Product Description
  • Table 88: FlashDirect-LC - Product Status
  • Table 89: FlashDirect-LC - Product Description
  • Table 90: University of Alberta Pipeline Products & Ongoing Clinical Trials Overview
  • Table 91: POC Device - Zika Virus - Product Status
  • Table 92: POC Device - Zika Virus - Product Description
  • Table 93: University of California, Berkeley Pipeline Products & Ongoing Clinical Trials Overview
  • Table 94: Microfluidic Blotting Device - Product Status
  • Table 95: Microfluidic Blotting Device - Product Description
  • Table 96: Multi-dimensional Microfluidic Device - Product Status
  • Table 97: Multi-dimensional Microfluidic Device - Product Description
  • Table 98: University of California, Davis Pipeline Products & Ongoing Clinical Trials Overview
  • Table 99: Blood Safety Microchip - Product Status
  • Table 100: Blood Safety Microchip - Product Description
  • Table 101: Wellstat Diagnostics, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 102: Electrochemiluminescent Based RNA Detection Platform - Product Status
  • Table 103: Electrochemiluminescent Based RNA Detection Platform - Product Description
  • Table 104: Xen Biofluidx Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 105: Xen System - Product Status
  • Table 106: Xen System - Product Description
  • Table 107: Glossary

List of Figures

  • Figure 1: Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development
  • Figure 2: Point-of-Care (POC) Analyzers - Pipeline Products by Territory
  • Figure 3: Point-of-Care (POC) Analyzers - Pipeline Products by Regulatory Path
  • Figure 4: Point-of-Care (POC) Analyzers - Pipeline Products by Estimated Approval Date
Back to Top